Alessandro Desideri

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Pharmaceutics

International journal of molecular sciences

Nutrients

Biomedicines

Università Roma Tor Vergata

University of Leicester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università Roma Tor Vergata Nov 01 1995

Italy

Full Professor Molecular Biology :: Biology

Università degli Studi di Messina Nov 01 1990 - Oct 31 1995

Italy

Full professor :: Chemistry e Biochemistry

Università degli Studi di Roma Tor Vergata Nov 01 1985 - Oct 31 1990

Italy

Associate Professor :: Biology

Education History

University of Leicester Jun 09 1982

United Kingdom

PHD :: Chemistry

Publications

Adelaide Teofani, Antonio Libonati, Valeria Unida, Silvia Biocca, Alessandro Desideri, Vincenzo Campanella
Coronal and Root Canal Microbiota in Apical Periodontitis with Different PAI. Microorganisms 12 (8) (2024)
Adelaide Teofani, Irene Marafini, Federica Laudisi, Daniele Pietrucci, Silvia Salvatori, Valeria Unida, Silvia Biocca, Giovanni Monteleone, Alessandro Desideri
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders. Nutrients 14 (2) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Daniele Pietrucci, Adelaide Teofani, Marco Milanesi, Bruno Fosso, Lorenza Putignani, Francesco Messina, Graziano Pesole, Alessandro Desideri, Giovanni Chillemi
Machine Learning Data Analysis Highlights the Role of Parasutterella and Alloprevotella in Autism Spectrum Disorders. Biomedicines 10 (8) (2022)
Alessio Ottaviani, Federico Iacovelli, Joshua Welsch, Blasco Morozzo Della Rocca, Alessandro Desideri, Mattia Falconi, Laurent Calcul, Bill J Baker, Paola Fiorani
Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B. Cells 11 (21) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Alessio Ottaviani, Joshua Welsch, Keli Agama, Yves Pommier, Alessandro Desideri, Bill J Baker, Paola Fiorani
From Antarctica to cancer research: a novel human DNA topoisomerase 1B inhibitor from Antarctic sponge Dendrilla antarctica . Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Bini Chhetri Soren, Jagadish Babu Dasari, Alessio Ottaviani, Beatrice Messina, Giada Andreotti, Alice Romeo, Federico Iacovelli, Mattia Falconi, Alessandro Desideri, Paola Fiorani
In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB. International journal of molecular sciences 22 (14) (2021)
Barbara Frigerio, Elena Luison, Alessandro Desideri, Federico Iacovelli, Chiara Camisaschi, Ettore C Seregni, Silvana Canevari, Alessandro Massimo Gianni
Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review. Biomedicines 9 (12) (2021)
Alessio Ottaviani, Federico Iacovelli, Paola Fiorani, Alessandro Desideri
Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB. International journal of molecular sciences 22 (8) (2021)
Giulia Vindigni, Sofia Raniolo, Federico Iacovelli, Valeria Unida, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
AS1411 Aptamer Linked to DNA Nanostructures Diverts Its Traffic Inside Cancer Cells and Improves Its Therapeutic Efficacy. Pharmaceutics 13 (10) (2021)
Daniele Pietrucci, Adelaide Teofani, Valeria Unida, Rocco Cerroni, Silvia Biocca, Alessandro Stefani, Alessandro Desideri
Can Gut Microbiota Be a Good Predictor for Parkinson's Disease? A Machine Learning Approach. Brain sciences 10 (4) (2020)
Silvia Lai, Alessio Molfino, Massimo Testorio, Adolfo M Perrotta, Annachiara Currado, Giovanni Pintus, Daniele Pietrucci, Valeria Unida, Davide La Rocca, Silvia Biocca, Alessandro Desideri
Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease. Nutrients 11 (12) (2019)
Sofia Raniolo, Federico Iacovelli, Valeria Unida, Alessandro Desideri, Silvia Biocca
In Silico and In Cell Analysis of Openable DNA Nanocages for miRNA Silencing. International journal of molecular sciences 21 (1) (2019)
Francesca Cardamone, Mattia Falconi, Alessandro Desideri
Molecular dynamics characterization of the SAMHD1 Aicardi-Goutières Arg145Gln mutant: structural determinants for the impaired tetramerization. Journal of computer-aided molecular design 32 (5) (2018)
Francesca Cardamone, Federico Iacovelli, Giovanni Chillemi, Mattia Falconi, Alessandro Desideri
A molecular dynamics simulation study decodes the early stage of the disassembly process abolishing the human SAMHD1 function. Journal of computer-aided molecular design 31 (5) (2017)

Alessandro Desideri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alessandro Desideri